Faezeh Tolue Ghasaban
Overview
Explore the profile of Faezeh Tolue Ghasaban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tolue Ghasaban F, Moghbeli M
Pathol Res Pract
. 2024 Oct;
263:155683.
PMID: 39471528
Tumor cell invasion is considered as one of the main therapeutic challenges in cancer patients, which leads to distant metastasis and reduced prognosis. Therefore, investigation of the factors involved in...
2.
Tolue Ghasaban F, Taghehchian N, Zangouei A, Keivany M, Moghbeli M
Pathol Res Pract
. 2024 Aug;
262:155547.
PMID: 39151250
Late diagnosis is considered one of the main reasons of high mortality rate among cancer patients that results in therapeutic failure and tumor relapse. Therefore, it is needed to evaluate...
3.
Tolue Ghasaban F, Ghanei M, Mahmoudian R, Taghehchian N, Abbaszadegan M, Moghbeli M
Heliyon
. 2024 May;
10(9):e30599.
PMID: 38726188
Pancreatic cancer (PC), as one of the main endocrine and digestive systems malignancies has the highest cancer related mortality in the world. Lack of the evident clinical symptoms and appropriate...
4.
Maharati A, Tolue Ghasaban F, Akhlaghipour I, Taghehchian N, Zangouei A, Moghbeli M
J Mol Histol
. 2023 Sep;
54(6):559-578.
PMID: 37759132
Therapeutic and diagnostic progresses have significantly reduced the mortality rate among cancer patients during the last decade. However, there is still a high rate of mortality among cancer patients. One...
5.
Tolue Ghasaban F, Maharati A, Zangouei A, Zangooie A, Moghbeli M
Cancer Cell Int
. 2023 Aug;
23(1):170.
PMID: 37587481
Although, there is a high rate of good prognosis in early stage head and neck tumors, about half of these tumors are detected in advanced stages with poor prognosis. A...
6.
Maharati A, Samsami Y, Latifi H, Tolue Ghasaban F, Moghbeli M
Cancer Cell Int
. 2023 Aug;
23(1):168.
PMID: 37580768
Chemotherapy is widely used as one of the first line therapeutic methods in cancer patients. However, chemotherapeutic resistance is one of the most common problems in cancer patients, which leads...
7.
Tolue Ghasaban F, Maharati A, Akhlaghipour I, Moghbeli M
Cancer Cell Int
. 2023 Apr;
23(1):80.
PMID: 37098542
Chemotherapy is one of the most common therapeutic methods in advanced and metastatic tumors. Cisplatin (CDDP) is considered as one of the main first-line chemotherapy drugs in solid tumors. However,...